These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8475560)

  • 1. Hepatic lidocaine metabolism and complications of cirrhosis. Implications for assessing patient priority for hepatic transplantation.
    Shiffman ML; Fisher RA; Sanyal AJ; Edinboro LE; Luketic VA; Purdum PP; Raymond P; Posner MP
    Transplantation; 1993 Apr; 55(4):830-5. PubMed ID: 8475560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The low-dose monoethylglycinexylidide test: assessment of liver function with fewer side effects.
    Reichel C; Nacke A; Sudhop T; Wienkoop G; Lüers C; Hahn C; Pohl C; Spengler U; Sauerbruch T
    Hepatology; 1997 Jun; 25(6):1323-7. PubMed ID: 9185746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery.
    Ercolani G; Grazi GL; Callivà R; Pierangeli F; Cescon M; Cavallari A; Mazziotti A
    Surgery; 2000 Apr; 127(4):464-71. PubMed ID: 10776439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.
    Oellerich M; Burdelski M; Lautz HU; Schulz M; Schmidt FW; Herrmann H
    Ther Drug Monit; 1990 May; 12(3):219-26. PubMed ID: 2349604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
    Shiffman ML; Luketic VA; Sanyal AJ; Thompson EB
    Ther Drug Monit; 1996 Aug; 18(4):372-7. PubMed ID: 8857553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of one-year pretransplant survival in patients with cirrhosis.
    Oellerich M; Burdelski M; Lautz HU; Binder L; Pichlmayr R
    Hepatology; 1991 Dec; 14(6):1029-34. PubMed ID: 1959850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis.
    Shiffman ML; Luketic VA; Sanyal AJ; Duckworth PF; Purdum PP; Contos MJ; Mills AS; Edinboro LE; Poklis A
    Hepatology; 1994 Apr; 19(4):933-40. PubMed ID: 8138268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability.
    Fairchild R; Solomon H; Contis J; Kaminski D
    Arch Surg; 1996 Oct; 131(10):1099-102. PubMed ID: 8857911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamic liver function study using the lidocaine test].
    Sídlová K; Průsa R
    Cas Lek Cesk; 2000 Sep; 139(19):604-5. PubMed ID: 11192753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical importance of conventional and quantitative liver function tests in liver transplantation.
    Tanaka E; Inomata S; Yasuhara H
    J Clin Pharm Ther; 2000 Dec; 25(6):411-9. PubMed ID: 11123494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic lidocaine metabolism is useful in the selection of patients in need of liver transplantation.
    Luketic VA; Shiffman ML; Fisher RA; Sanyal AJ; Purdum PP; Posner MP
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1072-4. PubMed ID: 8442046
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of lidocaine as a test of liver function in liver transplantation.
    Potter JM; Oellerich M
    Liver Transpl Surg; 1996 May; 2(3):211-24. PubMed ID: 9346651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of pretransplant prognosis in patients with cirrhosis.
    Oellerich M; Burdelski M; Lautz HU; Rodeck B; Duewel J; Schulz M; Schmidt FW; Brodehl J; Pichlmayr R
    Transplantation; 1991 Apr; 51(4):801-6. PubMed ID: 2014533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of the lidocaine-monoethylglycinexylidide test in the liver transplant recipient.
    Potter JM; Hickman PE; Henderson A; Balderson GA; Lynch SV; Strong RW
    Ther Drug Monit; 1996 Aug; 18(4):383-7. PubMed ID: 8857555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hypoxia on the hepatic metabolism of lidocaine in the isolated perfused pig liver.
    Mets B; Hickman R; Allin R; Van Dyk J; Lotz Z
    Hepatology; 1993 Apr; 17(4):668-76. PubMed ID: 8477972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients.
    Schroeder TJ; Gremse DA; Mansour ME; Theuerling AW; Brunson ME; Ryckman FC; Suchy FJ; Penn I; Alexander JW; Pesce AJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2299-301. PubMed ID: 2652744
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
    Kupcová V; Turecký L; Szántová M; Schmidtová K
    Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of monoethylglycinexylidide as a liver function test in the liver transplant recipient.
    Potter JM; Hickman PE; Lynch SV; Henderson A; Wright M; Balderson G; Strong RW
    Transplantation; 1993 Dec; 56(6):1385-8. PubMed ID: 8279008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.
    Zotz RB; von Schönfeld J; Erhard J; Breuer N; Lange R; Beste M; Goebell H; Eigler FW
    Transplantation; 1997 Feb; 63(4):538-41. PubMed ID: 9047147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.